New stock news | Nanhua Futures (603093.SH) Hong Kong IPO prospectus invalidated.
Nanhua Futures Co., Ltd. (referred to as Nanhua Futures) (603093.SH) submitted its Hong Kong prospectus on April 17th, which expired on October 17th after 6 months.
Nanhua Futures Co., Ltd. (referred to as Nanhua Futures) (603093.SH) submitted its Hong Kong IPO prospectus on April 17th, which expired after 6 months on October 17th, with CITIC SEC being its exclusive sponsor at the time of submission.
The prospectus disclosed that Nanhua Futures is a China-based financial services provider specializing in futures and derivatives. The company offers comprehensive and customized derivative products and risk management services for industrial clients, financial institutions, and individual investors. They also strive to provide more diversified wealth management services for Chinese and overseas investors. Nanhua Futures was listed on the Shanghai Stock Exchange in August 2019, making it the first futures company listed on A-share market in China. Since its listing, the company's total market value has exceeded 12.5 billion RMB.
Related Articles
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
RECOMMEND
